Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059) [Letter]

Rule, Simon A., Cartron, Guillaume, Fegan, Christopher ORCID: https://orcid.org/0000-0001-9685-0621, Morschhauser, Franck, Han, Lingling, Mitra, Siddhartha, Salles, Gilles and Dyer, Martin J. S. 2020. Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059) [Letter]. Leukemia 34 , pp. 1458-1461. 10.1038/s41375-019-0658-7

[thumbnail of FEGAN, Christopher - Long-term_follow-up_of_patients_with_mantle_cell_l (1).pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (583kB) | Preview
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Springer Nature
ISSN: 0887-6924
Date of First Compliant Deposit: 31 January 2020
Date of Acceptance: 17 November 2019
Last Modified: 05 May 2023 12:56
URI: https://orca.cardiff.ac.uk/id/eprint/129238

Citation Data

Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics